{"docstore/metadata": {"3e0bc612-9726-47b6-8d39-fea8d41445d6": {"doc_hash": "c6cd979bbebc749aef8894f461327ee2098b2515e818f3a0417223ce3d493f04"}, "3b01be66-e106-4973-887c-a800311733a2": {"doc_hash": "c9596c8ddc595e7e1ab039043de47d91fadb8aff8c0d8f57706bf6358315ad37"}, "56ccd84a-64ed-4fd8-9060-fafa7b722b45": {"doc_hash": "63210b80966b798df51ec9500a1d768901d7ef2823cbcb734ec185766fd86507"}, "05057b6e-926e-4bdb-a7ad-19996a7ad291": {"doc_hash": "1b7bc7228bf1743b0178c79e10527c0336640bf1cb7a3dd005ec3de2a1e6d27d"}, "3f32e08b-dc7f-46e4-8ba3-6f8ea4027f27": {"doc_hash": "2ebf91efaa1c319bf2d76af9bcb7177bf1e8d2103e59369613d86d6b5a9c6f13"}, "d3cda3cf-26fe-486c-89fb-b3026ab036f8": {"doc_hash": "a602c230fb436e566e9643d98bbdcffad0e55badcdef1eb557008b5a5c4597fd", "ref_doc_id": "3e0bc612-9726-47b6-8d39-fea8d41445d6"}, "12728f67-c4de-4de2-a926-d309ab8bcc0e": {"doc_hash": "35963f2a7168ddb67647805ce6d0416222329a0ac2a5c1eeaf8b9276376d0d2d", "ref_doc_id": "3b01be66-e106-4973-887c-a800311733a2"}, "ef453681-e053-4f6c-a79a-baf79a4f7dd0": {"doc_hash": "5850ad6c6b61c67bb939fd0ad2865da12deeae70b94f09a709b53730230c034a", "ref_doc_id": "56ccd84a-64ed-4fd8-9060-fafa7b722b45"}, "0a781e13-94ee-4b73-8080-f6b57397adbc": {"doc_hash": "07692953cc00a2d8ba01827982920f96b9a44ccf8c24b085721d134b1159275b", "ref_doc_id": "05057b6e-926e-4bdb-a7ad-19996a7ad291"}, "030b7ab6-3028-49f7-914e-896f96250d69": {"doc_hash": "3aece0f359e6fbd62b47fa721870c9d46c33dbc4ae3e8eb6cadadb5cf28f2a8f", "ref_doc_id": "3f32e08b-dc7f-46e4-8ba3-6f8ea4027f27"}}, "docstore/data": {"d3cda3cf-26fe-486c-89fb-b3026ab036f8": {"__data__": {"id_": "d3cda3cf-26fe-486c-89fb-b3026ab036f8", "embedding": null, "metadata": {"page_label": "1", "file_name": "celiscan_info.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3e0bc612-9726-47b6-8d39-fea8d41445d6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "celiscan_info.pdf"}, "hash": "c6cd979bbebc749aef8894f461327ee2098b2515e818f3a0417223ce3d493f04", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "###  In-Depth  Report  for  ScanAI  RAG  Agent  Integration:  CeliScan  Diagnostic  Tool   ####  Overview  CeliScan  is  a  cutting-edge  diagnostic  tool  designed  to  revolutionize  the  identification  and  \nmanagement\n \nof\n \nceliac\n \ndisease,\n \nan\n \nautoimmune\n \ndisorder\n \naffecting\n \napproximately\n \n1\n \nin\n \n100\n \nindividuals\n \nglobally.\n \nDespite\n \nits\n \nprevalence,\n \nceliac\n \ndisease\n \nremains\n \nunderdiagnosed,\n \nwith\n \nup\n \nto\n \n83%\n \nof\n \ncases\n \nunrecognized\n \nor\n \nmisdiagnosed\n \ndue\n \nto\n \nlimitations\n \nin\n \ntraditional\n \ndiagnostic\n \nmethods.\n \nCeliScan\n \nleverages\n \na\n \nmulti-modal\n \nmachine\n \nlearning\n \n(ML)\n \nframework\n \nto\n \nprovide\n \na\n \nhighly\n \naccurate,\n \nefficient,\n \nand\n \naccessible\n \ndiagnostic\n \nsolution.\n \nThis\n \nreport\n \noutlines\n \nthe\n \ntool\u2019s\n \nfunctionality,\n \ntechnical\n \nspecifications,\n \nand\n \nintegration\n \nconsiderations\n \nfor\n \nthe\n \nRetrieval-Augmented\n \nGeneration\n \n(RAG)\n \nagent,\n \nScanAI,\n \nto\n \nbe\n \nembedded\n \nwithin\n \nthe\n \nCeliScan\n \napp.\n  ---   ###  Purpose  and  Objectives  CeliScan  addresses  the  shortcomings  of  conventional  diagnostic  approaches\u2014such  as  \nserological\n \ntests,\n \ngenetic\n \nscreening,\n \nand\n \nendoscopic\n \nbiopsies\u2014which\n \nsuffer\n \nfrom\n \nfalse\n \nnegatives,\n \ndependency\n \non\n \ngluten\n \nexposure,\n \nhigh\n \ncosts,\n \nand\n \npatient\n \ndiscomfort.\n \nThe\n \ntool\n \naims\n \nto:\n 1.  Enhance  diagnostic  accuracy  through  multi-modal  data  integration.  2.  Reduce  reliance  on  invasive  procedures.  3.  Improve  early  detection  rates.  4.  Lower  healthcare  costs  and  improve  patient  comfort.  5.  Provide  an  accessible,  user-friendly  interface  for  both  patients  and  healthcare  providers.   ---   ###  Technical  Foundation  ####  Machine  Learning  Model  CeliScan  is  powered  by  a  Support  Vector  Machine  (SVM)  algorithm,  selected  for  its  superior  \nperformance\n \nin\n \na\n \ncomparative\n \nanalysis\n \nof\n \nvarious\n \nML\n \nmodels.\n \nThe\n \nmodel\n \nwas\n \ntrained\n \nand\n \nvalidated\n \non\n \na\n \ndataset\n \ncomprising\n \n2,206\n \npatient\n \nrecords,\n \nachieving:\n -  **Diagnostic  Accuracy**:  97.51%  -  **False  Negative  Rate**:  0%  -  **Outperformance**:  Significantly  surpasses  traditional  single-method  diagnostics.   ####  Training  Data  The  SVM  model  integrates  diverse  data  modalities,  including:  1.  **Serological  Markers**:  Levels  of  anti-tissue  transglutaminase  (tTG-IgA),  anti-endomysial  \nantibodies\n \n(EMA),\n \nand\n \ndeamidated\n \ngliadin\n \npeptide\n \n(DGP)\n \nantibodies.\n 2.  **Genetic  Information**:  Presence  of  HLA-DQ2  and  HLA-DQ8  haplotypes,  which  are  strongly  \nassociated\n \nwith\n \nceliac\n \ndisease.\n 3.  **Clinical  Symptoms**:  Patient-reported  symptoms  such  as  chronic  diarrhea,  abdominal  pain,  \nbloating,\n \nfatigue,\n \nand\n \nunexplained\n \nweight\n \nloss.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2809, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "12728f67-c4de-4de2-a926-d309ab8bcc0e": {"__data__": {"id_": "12728f67-c4de-4de2-a926-d309ab8bcc0e", "embedding": null, "metadata": {"page_label": "2", "file_name": "celiscan_info.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3b01be66-e106-4973-887c-a800311733a2", "node_type": "4", "metadata": {"page_label": "2", "file_name": "celiscan_info.pdf"}, "hash": "c9596c8ddc595e7e1ab039043de47d91fadb8aff8c0d8f57706bf6358315ad37", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "4.  **Anthropometric  Measurements**:  Metrics  like  short  stature,  body  mass  index  (BMI),  and  \nbody\n \ncomposition\n \nchanges.\n 5.  **Additional  Contextual  Data**:  Patient  history,  dietary  patterns,  and  family  history  of  \nautoimmune\n \ndisorders.\n  This  multi-modal  approach  mitigates  the  limitations  of  individual  tests  (e.g.,  false  negatives  in  \nserology\n \ndue\n \nto\n \ngluten-free\n \ndiets)\n \nby\n \nsynthesizing\n \na\n \ncomprehensive\n \ndiagnostic\n \nprofile.\n  ---   ###  Functionality  of  CeliScan  ####  User  Interface  CeliScan  offers  a  dual-purpose  interface  tailored  to:  -  **Patients**:  Self-assessment  by  inputting  symptoms,  dietary  habits,  and  optional  test  results.  -  **Healthcare  Providers**:  Detailed  diagnostic  input  including  lab  results,  genetic  data,  and  \nclinical\n \nobservations.\n  ####  Input  Modalities  The  tool  accepts  a  variety  of  data  types  across  multiple  categories:  1.  **Text-Based  Inputs**:     -  Symptom  descriptions  (e.g.,  frequency  and  severity  of  diarrhea  or  fatigue).     -  Medical  history  (e.g.,  prior  diagnoses,  family  history).     -  Dietary  information  (e.g.,  gluten  exposure  duration).  2.  **Numerical  Data**:     -  Serological  test  results  (e.g.,  tTG-IgA  levels  in  U/mL).     -  Anthropometric  measurements  (e.g.,  height,  weight,  BMI).  3.  **Categorical  Data**:     -  Genetic  screening  results  (e.g.,  HLA-DQ2  positive/negative).     -  Binary  symptom  presence  (e.g.,  yes/no  for  abdominal  pain).  4.  **Optional  Uploads**:     -  PDFs  or  text  files  of  lab  reports.     -  Images  of  physical  symptoms  (e.g.,  dermatitis  herpetiformis  rashes,  if  applicable).   ####  Processing  Workflow  1.  **Data  Collection**:  Users  input  data  via  a  structured  form  or  upload  relevant  files.  2.  **Preprocessing**:  The  system  standardizes  and  normalizes  inputs  (e.g.,  converting  units,  \nencoding\n \ncategorical\n \nvariables).\n 3.  **Model  Inference**:  The  SVM  processes  the  multi-modal  data  to  generate  a  diagnostic  \nprediction.\n 4.  **Output  Generation**:  A  detailed  report  is  produced,  including:     -  **Diagnosis**:  Positive  or  negative  for  celiac  disease.     -  **Certainty  Score**:  A  percentage  indicating  the  likelihood  of  the  result\u2019s  accuracy  (e.g.,  \n92.3%\n \ncertainty).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2400, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ef453681-e053-4f6c-a79a-baf79a4f7dd0": {"__data__": {"id_": "ef453681-e053-4f6c-a79a-baf79a4f7dd0", "embedding": null, "metadata": {"page_label": "3", "file_name": "celiscan_info.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "56ccd84a-64ed-4fd8-9060-fafa7b722b45", "node_type": "4", "metadata": {"page_label": "3", "file_name": "celiscan_info.pdf"}, "hash": "63210b80966b798df51ec9500a1d768901d7ef2823cbcb734ec185766fd86507", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "-  **Supporting  Evidence**:  Breakdown  of  contributing  factors  (e.g.,  elevated  tTG-IgA,  \npresence\n \nof\n \nHLA-DQ2).\n  ####  Output  Report  The  diagnostic  report  is  concise  yet  comprehensive,  designed  for  both  patient  understanding  \nand\n \nclinical\n \nuse:\n -  **Header**:  Patient  ID  (if  applicable),  date,  and  tool  version.  -  **Diagnosis**:  \u201cPositive  for  Celiac  Disease\u201d  or  \u201cNegative  for  Celiac  Disease.\u201d  -  **Certainty  Score**:  Expressed  as  a  percentage  (e.g.,  \u201c97.8%  likelihood  of  accuracy\u201d).  -  **Key  Indicators**:  List  of  inputs  most  influential  to  the  diagnosis  (e.g.,  \u201cHigh  tTG-IgA:  45  \nU/mL,\u201d\n \n\u201cChronic\n \ndiarrhea\n \nreported\u201d).\n -  **Recommendations**:  General  guidance  (e.g.,  \u201cConsult  a  gastroenterologist  for  confirmatory  \nbiopsy\n \nif\n \npositive\u201d\n \nor\n \n\u201cMonitor\n \nsymptoms\n \nif\n \nnegative\n \nwith\n \nlow\n \ncertainty\u201d).\n  ---   ###  Integration  with  ScanAI  (RAG  Agent)  ScanAI,  as  a  Retrieval-Augmented  Generation  agent,  will  enhance  CeliScan  by  providing  \ncontextual\n \nexplanations,\n \nanswering\n \nuser\n \nqueries,\n \nand\n \nretrieving\n \nrelevant\n \ninformation\n \nbased\n \non\n \nthe\n \ndiagnostic\n \nprocess.\n \nBelow\n \nare\n \nintegration\n \nspecifications:\n  ####  Role  of  ScanAI  1.  **Patient  Education**:     -  Explain  diagnostic  results  in  layman\u2019s  terms  (e.g.,  \u201cA  95%  certainty  score  means  the  tool  is  \nhighly\n \nconfident\n \nyou\n \nmay\n \nhave\n \nceliac\n \ndisease\u201d).\n    -  Provide  information  on  celiac  disease  symptoms,  management,  and  gluten-free  diets.  2.  **Clinical  Support**:     -  Offer  detailed  breakdowns  of  how  inputs  influenced  the  diagnosis  for  healthcare  providers.     -  Suggest  follow-up  tests  or  procedures  based  on  the  certainty  score  and  input  data.  3.  **Interactive  Queries**:     -  Respond  to  user  questions  like  \u201cWhy  does  my  genetic  result  matter?\u201d  or  \u201cWhat  does  a  false  \nnegative\n \nmean?\u201d\n    -  Retrieve  external  resources  (e.g.,  latest  research  or  guidelines)  if  permitted  by  app  settings.   ####  Data  Flow  to  ScanAI  -  **Input  Sharing**:  ScanAI  receives  the  full  diagnostic  report,  including  raw  inputs,  processed  \ndata,\n \nand\n \noutput\n \n(diagnosis\n \n+\n \ncertainty\n \nscore).\n -  **Memory  Utilization**:  Leverage  xAI\u2019s  memory  feature  to  recall  prior  user  interactions  (e.g.,  \n\u201cLast\n \ntime,\n \nyou\n \nreported\n \ndiarrhea\n \nbut\n \nno\n \ngenetic\n \ndata\u2014adding\n \nit\n \nincreased\n \ncertainty\n \nfrom\n \n85%\n \nto\n \n95%\u201d).\n -  **Real-Time  Processing**:  ScanAI  processes  queries  in  parallel  with  CeliScan\u2019s  diagnostic  \noutput,\n \nensuring\n \nseamless\n \nuser\n \nexperience.\n  ####  Customization  for  ScanAI", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2726, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0a781e13-94ee-4b73-8080-f6b57397adbc": {"__data__": {"id_": "0a781e13-94ee-4b73-8080-f6b57397adbc", "embedding": null, "metadata": {"page_label": "4", "file_name": "celiscan_info.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "05057b6e-926e-4bdb-a7ad-19996a7ad291", "node_type": "4", "metadata": {"page_label": "4", "file_name": "celiscan_info.pdf"}, "hash": "1b7bc7228bf1743b0178c79e10527c0336640bf1cb7a3dd005ec3de2a1e6d27d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "-  **Tone  and  Style**:  Adopt  a  supportive,  clear,  and  empathetic  tone  for  patients;  a  precise,  \ntechnical\n \ntone\n \nfor\n \nproviders.\n -  **Guardrails**:  Avoid  speculative  diagnoses  beyond  CeliScan\u2019s  output  (e.g.,  \u201cI  can\u2019t  diagnose  \nother\n \nconditions,\n \nbut\n \nhere\u2019s\n \nwhat\n \nCeliScan\n \nfound\u201d).\n -  **Image  Handling**:  If  users  upload  symptom  images,  ScanAI  can  describe  them  contextually  \n(e.g.,\n \n\u201cThis\n \nrash\n \nresembles\n \ndermatitis\n \nherpetiformis,\n \na\n \nceliac-related\n \ncondition\u201d)\n \nbut\n \nshould\n \nnot\n \ngenerate\n \nor\n \nedit\n \nimages\n \nunless\n \nexplicitly\n \nrequested\n \nand\n \nconfirmed.\n  ####  Example  Interaction  **User**:  \u201cWhy  did  I  get  a  positive  result  with  92%  certainty?\u201d    **ScanAI**:  \u201cCeliScan  analyzed  your  inputs:  elevated  tTG-IgA  (38  U/mL),  HLA-DQ2  positivity,  \nand\n \nchronic\n \nbloating.\n \nThese\n \nstrongly\n \nsuggest\n \nceliac\n \ndisease.\n \nThe\n \n92%\n \ncertainty\n \nreflects\n \nthe\n \nmodel\u2019s\n \nconfidence\n \nbased\n \non\n \n2,206\n \npatient\n \nrecords\n \nit\n \nwas\n \ntrained\n \non.\n \nI\n \nrecommend\n \ndiscussing\n \na\n \nbiopsy\n \nwith\n \nyour\n \ndoctor\n \nto\n \nconfirm.\u201d\n  ---   ###  Benefits  and  Impact  -  **Accuracy**:  97.51%  diagnostic  precision  with  no  false  negatives,  outperforming  traditional  \nmethods.\n -  **Accessibility**:  Non-invasive  and  cost-effective,  usable  in  diverse  settings  (e.g.,  rural  clinics,  \nhome\n \nuse).\n -  **Scalability**:  Multi-modal  framework  can  adapt  to  additional  data  types  or  diseases  with  \nretraining.\n -  **Patient  Empowerment**:  Equips  users  with  actionable  insights  and  reduces  diagnostic  \ndelays.\n  ---   ###  Considerations  for  ScanAI  Integration  1.  **Privacy**:  Ensure  compliance  with  HIPAA  or  equivalent  standards;  anonymize  data  shared  \nwith\n \nScanAI.\n 2.  **Memory  Management**:  Allow  users  to  delete  prior  diagnostic  sessions  via  the  app\u2019s  \u201cData  \nControls\u201d\n \n(aligned\n \nwith\n \nxAI\u2019s\n \nmemory\n \nfeature).\n 3.  **Error  Handling**:  If  inputs  are  incomplete,  ScanAI  should  prompt  users  (e.g.,  \u201cAdding  \ngenetic\n \ndata\n \ncould\n \nimprove\n \naccuracy\u2014do\n \nyou\n \nhave\n \nit?\u201d).\n 4.  **Updates**:  Sync  ScanAI\u2019s  knowledge  base  with  CeliScan\u2019s  evolving  dataset  as  new  patient  \nrecords\n \nare\n \nincorporated.\n  ---   ###  Conclusion  CeliScan  represents  a  paradigm  shift  in  celiac  disease  diagnosis,  combining  advanced  ML  with  \nuser-friendly\n \ndesign.\n \nBy\n \nintegrating\n \nScanAI,\n \nthe\n \ntool\n \ngains\n \nan\n \nintelligent,\n \ninteractive\n \nlayer\n \nthat", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2552, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "030b7ab6-3028-49f7-914e-896f96250d69": {"__data__": {"id_": "030b7ab6-3028-49f7-914e-896f96250d69", "embedding": null, "metadata": {"page_label": "5", "file_name": "celiscan_info.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3f32e08b-dc7f-46e4-8ba3-6f8ea4027f27", "node_type": "4", "metadata": {"page_label": "5", "file_name": "celiscan_info.pdf"}, "hash": "2ebf91efaa1c319bf2d76af9bcb7177bf1e8d2103e59369613d86d6b5a9c6f13", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "enhances  usability  and  education.  This  synergy  positions  CeliScan  as  a  transformative  solution,  \nbridging\n \ndiagnostic\n \ngaps\n \nand\n \nimproving\n \noutcomes\n \nfor\n \nmillions\n \nof\n \nundiagnosed\n \nindividuals\n \nworldwide.\n  ---    This  report  provides  ScanAI  with  a  comprehensive  blueprint  of  CeliScan\u2019s  functionality,  enabling  \nseamless\n \nintegration\n \nand\n \noptimal\n \nperformance\n \nwithin\n \nthe\n \napp.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 423, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/ref_doc_info": {"3e0bc612-9726-47b6-8d39-fea8d41445d6": {"node_ids": ["d3cda3cf-26fe-486c-89fb-b3026ab036f8"], "metadata": {"page_label": "1", "file_name": "celiscan_info.pdf"}}, "3b01be66-e106-4973-887c-a800311733a2": {"node_ids": ["12728f67-c4de-4de2-a926-d309ab8bcc0e"], "metadata": {"page_label": "2", "file_name": "celiscan_info.pdf"}}, "56ccd84a-64ed-4fd8-9060-fafa7b722b45": {"node_ids": ["ef453681-e053-4f6c-a79a-baf79a4f7dd0"], "metadata": {"page_label": "3", "file_name": "celiscan_info.pdf"}}, "05057b6e-926e-4bdb-a7ad-19996a7ad291": {"node_ids": ["0a781e13-94ee-4b73-8080-f6b57397adbc"], "metadata": {"page_label": "4", "file_name": "celiscan_info.pdf"}}, "3f32e08b-dc7f-46e4-8ba3-6f8ea4027f27": {"node_ids": ["030b7ab6-3028-49f7-914e-896f96250d69"], "metadata": {"page_label": "5", "file_name": "celiscan_info.pdf"}}}}